Phase 1 — Early testing in a small group of people (usually 20–80) to evaluate safety, determine safe dosage, and identify side effects.
Trial locations(3 sites)
United States
UH Rainbow Babies & Children's Hospital, Cleveland, Ohio South Korea
National Cancer Center, Gyeonggi-do Korea Institute of Radiological & Medical Sciences, Seoul